Promakhos Therapeutics
A therapeutics platform for curing inflammatory disorders
Boston, United States · Founded 2021 · $397K raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Website
- promakhos.com
- Total Funding
- $397K
- Last Round
- $125K Pre-Seed
- Rounds
- 2
About
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
Summary
Promakhos Therapeutics is a Healthcare company based in Boston, United States, founded in 2021. It has raised $397K in total across 2 rounds. Investors include HHS, Asymmetry Ventures and Pioneer Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...